4 research outputs found
Proteomic Biomarkers for Acute Interstitial Lung Disease in Gefitinib-Treated Japanese Lung Cancer Patients
Interstitial lung disease (ILD) events have been reported in Japanese non-small-cell lung cancer (NSCLC) patients receiving EGFR tyrosine kinase inhibitors. We investigated proteomic biomarkers for mechanistic insights and improved prediction of ILD. Blood plasma was collected from 43 gefitinib-treated NSCLC patients developing acute ILD (confirmed by blinded diagnostic review) and 123 randomly selected controls in a nested case-control study within a pharmacoepidemiological cohort study in Japan. We generated ∼7 million tandem mass spectrometry (MS/MS) measurements with extensive quality control and validation, producing one of the largest proteomic lung cancer datasets to date, incorporating rigorous study design, phenotype definition, and evaluation of sample processing. After alignment, scaling, and measurement batch adjustment, we identified 41 peptide peaks representing 29 proteins best predicting ILD. Multivariate peptide, protein, and pathway modeling achieved ILD prediction comparable to previously identified clinical variables; combining the two provided some improvement. The acute phase response pathway was strongly represented (17 of 29 proteins, p = 1.0×10−25), suggesting a key role with potential utility as a marker for increased risk of acute ILD events. Validation by Western blotting showed correlation for identified proteins, confirming that robust results can be generated from an MS/MS platform implementing strict quality control
Extended Coverage of Singly and Multiply Phosphorylated Peptides from a Single Titanium Dioxide Microcolumn
We developed a novel approach to
enlarge phosphoproteome coverage
by selective elution depending on the number of phosphoryl group of
peptides from a single titanium dioxide (TiO<sub>2</sub>) microcolumn
using hydrophilic interaction chromatography (HILIC). In this approach,
acidic methylphosphonate buffer including organic solvent is used
for selective elution of singly phosphorylated peptides from an aliphatic
hydroxy acid-modified metal oxide chromatography (HAMMOC) microcolumn
and basic elution conditions with phosphate, ammonium hydroxide, and
pyrrolidine are then employed for eluting multiply phosphorylated
peptides retained by the HAMMOC microcolumn. Finally, we successfully
identified 11 300 nonredundant phosphopeptides from triplicate
analyses of 100 μg of HeLa cell lysates using this approach.
This simple strategy made it possible to accomplish comprehensive
and efficient phosphoproteome analysis from limited sample amounts
loaded onto a single HAMMOC microcolumn without additional fractionation
or enrichment approaches
Extended Coverage of Singly and Multiply Phosphorylated Peptides from a Single Titanium Dioxide Microcolumn
We developed a novel approach to
enlarge phosphoproteome coverage
by selective elution depending on the number of phosphoryl group of
peptides from a single titanium dioxide (TiO<sub>2</sub>) microcolumn
using hydrophilic interaction chromatography (HILIC). In this approach,
acidic methylphosphonate buffer including organic solvent is used
for selective elution of singly phosphorylated peptides from an aliphatic
hydroxy acid-modified metal oxide chromatography (HAMMOC) microcolumn
and basic elution conditions with phosphate, ammonium hydroxide, and
pyrrolidine are then employed for eluting multiply phosphorylated
peptides retained by the HAMMOC microcolumn. Finally, we successfully
identified 11 300 nonredundant phosphopeptides from triplicate
analyses of 100 μg of HeLa cell lysates using this approach.
This simple strategy made it possible to accomplish comprehensive
and efficient phosphoproteome analysis from limited sample amounts
loaded onto a single HAMMOC microcolumn without additional fractionation
or enrichment approaches